Αποτελέσματα Αναζήτησης
Cannabis remains by far the most commonly consumed illicit drug in Europe. On this page, you can find the latest analysis of the drug situation for cannabis in Europe, including prevalence of use, treatment demand, seizures, price and purity, harms and more.
6 Ιαν 2012 · It combines information from EMCDDA routine reporting — data on patterns of prevalence and use, seizures, police reports, drug-law offences, cannabis potency and retail market prices — with literature on cannabis markets to create an in-depth analysis of the issue in a European context.
For example, there have been recent debates on medical cannabis in the European Parliament, and there has been some effort to reach a common EU position on voting on the reclassification of cannabis within the international drug control system.
23 Σεπ 2021 · Between 2010 and 2019, past-month prevalence of cannabis use increased by 27% in European adults (from 3·1 to 3·9%), with most pronounced relative increases observed among 35-64 year-olds. In 13 out of 26 countries, over 20% of all past-month users reported high-risk use patterns.
1 Ιουν 2022 · Cannabis is the world's most widely cultivated and consumed illicit drug, but there remain major gaps in our understanding of global cannabis markets. For example, it appears that premium ...
Although the use of medicinal cannabis is legal in many countries, for example to treat chronic pain, poor appetite, or nausea due to chemotherapy, legalisation of non-medicinal or recreational cannabis is a topic of growing public discussion and debate globally.
20 Μαρ 2024 · In Europe, expected regulatory reforms and growing acceptance of both medical and recreational cannabis use are contributing to a robust growth in the cannabis sector. The European market is becoming increasingly sophisticated, with a regulatory focus on consistency and compliance.
